Nicola Fiotti Selected Research

Group II Phospholipases A2

1/2018	Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study.
10/2014	Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study.
6/2013	Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Fiotti Research Topics

Disease

7	Sepsis (Septicemia) 01/2022 - 06/2013
4	Abdominal Aortic Aneurysm 05/2022 - 09/2002
4	Inflammation (Inflammations) 04/2021 - 08/2007
4	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 08/2007
4	Acute Coronary Syndrome 05/2009 - 10/2002
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2022 - 10/2014
3	Neoplasms (Cancer) 01/2018 - 06/2013
3	Stable Angina 07/2008 - 10/2002
2	Infections 05/2022 - 01/2018
2	COVID-19 01/2022 - 08/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 03/2011
2	Insulin Resistance 04/2021 - 01/2018
2	Aneurysm (Aneurysms) 01/2018 - 09/2002
2	Atherosclerosis 01/2018 - 08/2008
2	Non-ST Elevated Myocardial Infarction 03/2011 - 08/2007
2	Stroke (Strokes) 03/2011 - 09/2010
2	Unstable Angina 08/2007 - 10/2002
1	Endoleak 05/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Fatigue 10/2021
1	Dyslipidemias (Dyslipidemia) 10/2021
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 10/2021
1	Muscular Diseases (Myopathy) 10/2021
1	Myalgia 10/2021
1	Rhabdomyolysis 10/2021
1	Myotoxicity 10/2021
1	Pneumonia (Pneumonitis) 08/2021
1	Myocardial Infarction 04/2019
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2019
1	Cachexia 01/2019
1	Hyperglycemia 01/2018
1	Hyperthermia 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Leukocytosis (Pleocytosis) 01/2018
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Critical Illness (Critically Ill) 09/2017
1	Acute Disease 09/2017
1	Growth Disorders 09/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Communicable Diseases (Infectious Diseases) 06/2013

Drug/Important Bio-Agent (IBA)

10	Matrix Metalloproteinases (MMPs)IBA 05/2022 - 09/2002
8	Biomarkers (Surrogate Marker)IBA 05/2022 - 05/2009
4	ProcalcitoninIBA 01/2018 - 06/2013
4	C-Reactive ProteinIBA 01/2018 - 10/2002
3	Group II Phospholipases A2IBA 01/2018 - 06/2013
3	Proteins (Proteins, Gene)FDA Link 09/2017 - 06/2013
3	CyclinsIBA 01/2014 - 08/2007
2	Metalloproteases (Metalloproteinases)IBA 05/2022 - 06/2016
2	Glutathione (Reduced Glutathione)IBA 01/2018 - 01/2018
2	Phospholipases A2 (Phospholipase A2)IBA 10/2014 - 06/2013
2	Tissue Inhibitor of Metalloproteinase-1IBA 07/2008 - 08/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 08/2007 - 10/2002
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2007 - 06/2006
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2005 - 07/2004
1	LigandsIBA 01/2022
1	growth arrest-specific protein 6IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2021
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 10/2021
1	Nucleic AcidsIBA 08/2021
1	Glucose (Dextrose)FDA LinkGeneric 04/2021
1	AntioxidantsIBA 04/2021
1	Carrier Proteins (Binding Protein)IBA 04/2019
1	Galectin 3 (LGALS3)IBA 04/2019
1	CarbohydratesIBA 01/2019
1	Muscle Proteins (Muscle Protein)IBA 01/2019
1	serum P-component (CIt)IBA 01/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	HomocysteineIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	HDL CholesterolIBA 01/2018
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2018
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2018
1	CelluloseIBA 08/2017
1	E2F1 Transcription FactorIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 10/2014
1	Angiopoietin-2IBA 10/2014
1	Proteasome InhibitorsIBA 01/2014
1	Bortezomib (Velcade)FDA Link 01/2014
1	Lipocalin-2IBA 06/2013
1	AdrenomedullinIBA 06/2013
1	Natriuretic PeptidesIBA 06/2013
1	Therapeutic UsesIBA 06/2013
1	Thrombopoietin (c-mpl Ligand)IBA 06/2013

Therapy/Procedure

9	Therapeutics 10/2021 - 08/2007
2	Bed Rest (Bedrest) 04/2021 - 01/2018
2	Photochemotherapy (Photodynamic Therapy) 03/2007 - 06/2006
1	Endovascular Aneurysm Repair 05/2022
1	Secondary Prevention 10/2021
1	Total Parenteral Nutrition 01/2018
1	Radiotherapy 01/2018
1	Drug Therapy (Chemotherapy) 06/2013